Table 2.

List of measures and data collection schedule.

	Baseline	Follow-up month
		3	6
Questionnaires
Juniper Asthma Control Questionnaire (ACQ)	X	X	X
Juniper Mini Asthma-specific Quality of Life Questionnaire (mini-AQLQ)	X	X	X
Quality of Life Scales: Importance, Satisfaction, asthma impact	X	X	X
Two-week asthma symptom diary	X	X	X
Multiple-pass 24-hour diet recalls	X	X	X
Eating Habits Confidence Survey	X	X	X
Social Support and Eating Habits Survey	X	X	X
Stanford Seven-day Physical Activity Recall	X	X	X
Nine-item Patient Health Questionnaire	X		X
12-item Short Form Health Survey (SF-12)	X		X
Berlin Questionnaire for Sleep Apnea	X		X
Pittsburgh Sleep Quality Index	X		X
Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS)	X		X
Symptoms and adverse events	X	X	X
Care at non-Kaiser health care facilities	X	X	X
Demographics, age of asthma onset, and asthma triggers	X
Physical and laboratory measurements
Height	X
Weight, waist circumference, and blood pressure	X	X	X
Forced spirometry: FEV1, FVC, and FEV1/FVC (absolute and % predicted for all)	X	X	X
Exhaled breath condensate pH	X	X
Fractional exhaled nitric oxide (FeNO)	X	X	X
Fasting blood specimens: complete blood count (total and differential leukocyte counts); blood lipids; serum carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene), folate, and vitamin B12; serum cytokines (e.g., IL-5, IL-6, IL-13, IL-17, TNF-α, and IFN-γ);	X	X
Serum total and allergen-specific IgEs	X	X	X
Genotypes (e.g., glutathione S transferase and microsomal epoxide hydrolase genes)	X
Data from Patients' Electronic Health Recordsa
Diagnoses	X
Medications prescribed and dispensed	X		X
Health care encounters (e.g., office, ER/hospital)	X		X
Recruitment and intervention process measures (monitored continuously)
Safety of participants in the intervention arm (monitored continuously)

^aData will be extracted for 6 months before and after randomization.